Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 7 (2010), Issue 5 (May)

1. Intramedullary papillary ependymoma with choroid plexus differentiation and cerebrospinal fluid dissemination to the brain.
   J Neurosurg Pediatr, 5(5): 511-7. [Abstract] [Full-text]
2. Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumors.
   J Neurosurg Pediatr, 5(5): 486-99. [Abstract] [Full-text]
3. Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions.
   J Neurosurg Pediatr, 5(5): 479-85. [Abstract] [Full-text]
4. Neurogenic stunned myocardium after acute hydrocephalus.
   J Neurosurg Pediatr, 5(5): 428-33. [Abstract] [Full-text]
5. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
   J Neurosurg, 112(5): 990-6. [Abstract] [Full-text]
6. A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme.
   J Neurosurg, 112(5): 997-1004. [Abstract] [Full-text]
7. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
   J Neurosurg, 112(5): 925-33. [Abstract] [Full-text]
8. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
   J Neurosurg, 112(5): 940-50. [Abstract] [Full-text]
9. Biopsy versus resection in the management of malignant gliomas: a systematic review and meta-analysis.
   J Neurosurg, 112(5): 1020-32. [Abstract] [Full-text]
10. Implication of 5-aminolevulinic acid fluorescence of the ventricular wall for postoperative communicating hydrocephalus associated with cerebrospinal fluid dissemination in patients with glioblastoma multiforme: a report of 7 cases.
    J Neurosurg, 112(5): 1015-9. [Abstract] [Full-text]
11. Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy.
    J Neurosurg, 112(5): 920-4. [Abstract] [Full-text]
12. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway.
    J Neurosurg, 112(5): 934-9. [Abstract] [Full-text]
13. Surgical management of lateral-ventricle metastases: report of 29 cases in a single-institution experience.
    J Neurosurg, 112(5): 1046-55. [Abstract] [Full-text]
14. Risk profile associated with convexity meningioma resection in the modern neurosurgical era.
    J Neurosurg, 112(5): 913-9. [Abstract] [Full-text]
15. Patients' perceptions of awake and outpatient craniotomy for brain tumor: a qualitative study.
    J Neurosurg, 112(5): 1056-60. [Abstract] [Full-text]
16. Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet.
    J Nucl Med, 51(5): 728-34. [Abstract] [Full-text]
17. Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma.
    J Nucl Med, 51(5): 720-7. [Abstract] [Full-text]
18. Effects of concomitant temozolomide and radiation therapies on WT1-specific T-cells in malignant glioma.
    Jpn J Clin Oncol, 40(5): 395-403. [Abstract] [Full-text]
19. Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas.
    Jpn J Clin Oncol, 40(5): 388-94. [Abstract] [Full-text]
20. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma.
    CA Cancer J Clin, 60(3): 166-93. [Abstract] [Full-text]
21. The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response.
    J Clin Endocrinol Metab, 95(5): 2334-42. [Abstract] [Full-text]
22. Sleep-disordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls.
    J Clin Endocrinol Metab, 95(5): 2211-8. [Abstract] [Full-text]
23. A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs.
    J Clin Endocrinol Metab, 95(5): 2497-502. [Abstract] [Full-text]
24. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.
    J Clin Oncol, 28(14): 2467-74. [Abstract] [Full-text]
25. Epstein-Barr virus-associated intracranial leiomyosarcoma in an HIV-positive adolescent.
    J Pediatr Hematol Oncol, 32(4): e144-7. [Abstract] [Full-text]
26. Correlation between argyrophilic nucleolar organizer region staining and brain tumor classification and grading.
    Cancer Invest, 28(5): 459-64. [Abstract] [Full-text]
27. MYCN oncoprotein targets and their therapeutic potential.
    Cancer Lett, 293(2): 144-57. [Abstract] [Full-text]
28. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
    Int J Radiat Oncol Biol Phys, 77(2): 537-41. [Abstract] [Full-text]
29. Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression.
    Hum Pathol, 41(6): 815-23. [Abstract] [Full-text]
30. CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).
    Exp Cell Res, 316(9): 1553-66. [Abstract] [Full-text]
31. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.
    Cancer Cell, 17(5): 510-22. [Abstract] [Full-text]
32. Inhibition of Aurora Kinase A enhances chemosensitivity of medulloblastoma cell lines.
    Pediatr Blood Cancer, 55(1): 35-41. [Abstract] [Full-text]
33. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
    Pediatr Blood Cancer, 55(1): 42-6. [Abstract] [Full-text]
34. MIB-1 labeling index correlated with magnetic resonance imaging detected tumor volume doubling time in pituitary adenoma.
    Eur J Endocrinol, 162(6): 1027-33. [Abstract] [Full-text]
35. Possibilities of new therapeutic strategies in brain tumors.
    Cancer Treat Rev, 36(4): 335-41. [Abstract] [Full-text]
36. EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity.
    Cancer Lett, 294(1): 101-10. [Abstract] [Full-text]
37. Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities.
    Neurology, 74(21): 1724-31. [Abstract] [Full-text]
38. Association between YKL-40 and adult primary astrocytoma.
    Cancer, 116(11): 2688-97. [Abstract] [Full-text]
39. Risk factors for fatigue severity in primary brain tumor patients.
    Cancer, 116(11): 2707-15. [Abstract] [Full-text]
40. A cross-disciplinary approach to understanding neural stem cells in development and disease.
    Development, 137(12): 1933-8. [Abstract] [Full-text]
41. Cigarette smoking and risk of acoustic neuromas and pituitary tumours in the Million Women Study.
    Br J Cancer, 102(11): 1654-6. [Abstract] [Full-text]
42. Antitumor cytotoxic T-cell response induced by a survivin peptide mimic.
    Cancer Immunol Immunother, 59(8): 1211-21. [Abstract] [Full-text]
43. Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells.
    J Neuropathol Exp Neurol, 69(6): 606-22. [Abstract] [Full-text]
44. The side population of gliomas exhibits decreased cell migration.
    J Neuropathol Exp Neurol, 69(6): 623-31. [Abstract] [Full-text]
45. Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation.
    J Neuropathol Exp Neurol, 69(6): 632-42. [Abstract] [Full-text]
46. RapidArc radiation therapy: first year experience at the University of Alabama at Birmingham.
    Int J Radiat Oncol Biol Phys, 77(3): 932-41. [Abstract] [Full-text]
47. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.
    Int J Radiat Oncol Biol Phys, 77(3): 655-61. [Abstract] [Full-text]
48. Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide.
    Int J Radiat Oncol Biol Phys, 77(3): 670-6. [Abstract] [Full-text]
49. Randomized comparison of whole brain radiotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice-daily fractions, for brain metastases.
    Int J Radiat Oncol Biol Phys, 77(3): 648-54. [Abstract] [Full-text]
50. Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.
    Int J Radiat Oncol Biol Phys, 77(3): 662-9. [Abstract] [Full-text]
51. Modulation of hyaluronan production by CD44 positive glioma cells.
    Int J Cancer, 127(3): 532-42. [Abstract] [Full-text]
52. Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas.
    Int J Cancer, 127(3): 598-611. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.